1Q24 Analyst Presentation

16 May 2024

1

Agenda

1Q24 Summary

Company Update

Our Network Hospital - Group 2

Operational Statistics

Financial Highlights

2

1Q24 SUMMARY

3

1Q24 Operational and Financial Summary

1Q24 Highlights

1Q24

% Chg

% to

Revenue

Operating income

11%

THB 26,930 mm

Hospital revenue

11%

THB 25,526 mm

Breakdown by nationality

▪

Thai

10%

70%

▪

International

12%

30%

Breakdown by location

▪

Bangkok & Vicinity

8%

54%

▪

Outside Bangkok

14%

46%

Breakdown by type of patients

▪

Outpatients

12%

49%

▪

Inpatients

9%

51%

Remark: - Operating income is calculated from hospital revenue + revenue from sales of goods + other income

- All operational statistics are from BDMS management report

Profitability and Ratio

(THB mm)

1Q24

1Q23

Chg. (yoy)

EBITDA

6,778

5,987

13%

EBITDA margin

25.2%

24.6%

EBIT

5,371

4,630

16%

EBIT margin

19.9%

19.0%

Net profit

4,074

3,468

17%

Net profit margin

15.1%

14.3%

Remark: Margin was calculated as a percentage of operating income

Hospital

+11%

NPAT

+17%

Revenue

Key growth drivers are

▪ Growth of Thai and Inter

▪ Inter and Thai patient

patients

revenue

▪

Favorable cost control

▪ Upcountry hospitals

▪

Effective financial

management

4

1Q24 Key Growth Drivers: International Patients

Top 10 Nationality by Revenue in 1Q24

% Growth

YoY

1

Cambodia

-2%

2

China

+45%

3

USA

+19%

4

Japan

+7%

5

UK

+5%

6

Germany

+18%

7

Myanmar

-3%

8

France

+29%

9

Russia

+8%

10

UAE

+10%

Total International

+12%

China has the highest growth

Mainly from

  • Respiratory
  • Trauma
  • IVF, OBGYN and pediatrics
  • Well being (Dental, Skin, Check Up)

Inter Patient Revenue Growth by Region (YoY)

1Q24

+25%

Apr 24

+18% +18%

+2%

Flat

Europe

Middle East

CLMV

-4%

5

+49% YoY

SAUDI ARABIA

REVENUE in 1Q24

BDMS Saudi Arabia Collaboration Center in Riyadh with Saudi

staff

6

1Q24 Key Growth Drivers: Upcountry Hospitals

Strong Hospital Revenue Growth at Tourist Destinations Leading to Profitability Improvement

1Q24 Hospital Revenue Growth

OUTSIDE BKK

46%

CHIANGMAI

+14% YoY

1Q24

Revenue

22% YoY

HOSPITAL REVENUE

54%

+11% YoY

BKK

+8% YoY

OUTSIDE BANGKOK EBITDA MARGIN IMPROVEMENT

24.6%

26.1%

PATTAYA

15% YoY

20.2%

RAYONG

31% YoY

OUTSIDE BKK

PHUKET

2019

2023

1Q24

14% YoY

# of hospitals

31

35

36

7

COMPANY UPDATE

8

Center of Excellence

14 Centers of Excellence Providing Consultations and State of the Art Treatment

1Q24

Hospital revenue growth

CENTER of

+9% YoY

EXCELLENCE

Revenue contribution

(1Q24)

Non COE

41%

Hospital

Revenue

COE 59%

Remark:- 5 COEs in Bangkok, 8 COEs in upcountry and 1 COE in Cambodia

TRAUMA HEART ORTHOPEDICS

CANCER NEURO

EBITDA contribution

(1Q24)

with ~27% EBITDA Margin

Non COE

38%

Hospital

EBITDA

COE 62%

9

Wattnosoth Cancer Hospital

Comprehensive Cancer Treatment Services with Advanced Technologies in Collaboration with Multidisciplinary Team

Cancer 5-Year Survival Rate by Cancer Type (2022)

91.2% 94.0%

SEER WSH

65.0%

52.0%

39.0%

26.7%

Breast cancer

Colorectal cancer

Lung cancer

SEER = National cancer institute

WSH = Wattanosoth Cancer Hospital

10

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Bangkok Dusit Medical Services pcl published this content on 16 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 May 2024 07:23:03 UTC.